NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%
NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%
Hexagon Nutrition

Hexagon Nutrition

IPO
Issue: 138.87 CrPrice: ₹ 42.00
View Details

Hexagon Nutrition Raises ₹41.66 Crore from Anchor Investors Ahead of IPO

Hexagon Nutrition Limited has successfully allotted 92,57,696 equity shares to anchor investors at the anchor investor offer price of ₹45 per equity share, raising ₹41.66 crore ahead of its proposed initial public offering (IPO). The company has reserved the allotment for a diverse set of investors, including Bandhan Small Cap Fund, Ampersand Growth Opportunities Fund Scheme-I, CP Capital Limited, Visionary Value Fund, and Innovative Vision Fund.

The anchor book saw significant participation from Bandhan Small Cap Fund, which was the only domestic mutual fund participant in the anchor book. The fund was allotted shares worth approximately ₹12 crore, while Ampersand Growth Opportunities Fund Scheme-I received an allocation of approximately ₹10 crore. CP Capital Limited was allotted shares worth approximately ₹9.65 crore, and Visionary Value Fund and Innovative Vision Fund received allocations of approximately ₹5 crore each.

InvestorNumber of SharesAllocation (₹ Crore)
Bandhan Small Cap Fund26,66,66412
Ampersand Growth Opportunities Fund Scheme-I2,00,00010
CP Capital Limited1,83,3339.65
Visionary Value Fund1,83,3335
Innovative Vision Fund1,83,3335

Read also: Hexagon Nutrition Secures Rs 41.65 Crore from Five Anchor Investors Ahead of June 5 IPO Debut

No bids or applications were received from life insurance companies and pension funds in the anchor investor portion. The anchor allocation details were filed with the stock exchanges on June 4, 2026.

Hexagon Nutrition's IPO is set to open for subscription tomorrow, Friday, 5 June, and will close on Tuesday, 9 June. The company aims to raise ₹139 crore from the issue, with a price band of ₹42-45 per share. The IPO consists entirely of an offer for sale (OFS) of up to 30.86 million equity shares and does not include any fresh issue component.

The company has reserved 50% of the net issue for qualified institutional buyers (QIBs), 35% for retail investors, and 15% for non-institutional investors (NIIs). Existing shareholders Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar will dilute their holdings through the OFS.

Founded in 1993, Hexagon Nutrition is a research-focused nutrition company offering micronutrient premixes, therapeutic nutrition products, and clinical nutrition solutions. The company provides exposure to India's growing nutrition, wellness, and micronutrient market, although investors should carefully evaluate the risks highlighted in the Red Herring Prospectus (RHP).

Read also: SpaceX Sets Terms for Initial Public Offering; Details of Order Process Unveiled

In terms of financials, for FY25, revenue from operations increased 9% year-on-year to ₹324.92 crore from ₹297.7 crore in FY24. Profit after tax (PAT) surged 99.5% to ₹24.3 crore from ₹12.2 crore a year earlier. Margin performance remained healthy at 12.33% in FY25, compared with 8.36% in FY24 and 6.17% in FY23.

Investor Takeaway

Investors should be aware of Hexagon Nutrition's pre-IPO placement and its potential impact on the company's IPO.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.